Evaluation of analgesic effect of Intravenous Ketamine and Intravenous Fentanyl in adult patients with acute pain, in Emergency Department, Sina Hospital

Evaluation of analgesic effect of Intravenous sub dissociative ketamine and Intravenous fentanyl in adult patients with acute pain, in Emergency Department, Sina Hospital, 1395 - 1398

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180130038568N1

Enrollment

200

Registered

2018-02-15

Start date

2016-03-20

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute pain in Emergency Room. Pain, unspecified

Interventions

Intervention 1: Intervention group: Prescribing intravenous Ketamine in dose 0.3 mg per kg for adult patients in Emergency Room that suffering acute pain and the pain score is above 5/10. Intervention

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Any admitted adult patient in Emergency Room He or she has acute and sever pain The pain score is above 5/10

Exclusion criteria

Exclusion criteria: Pain score = 5 Pregnancy and post-partum women Allergy to ketamine or fentanyl Body weight = 46 kg or = 115 Altered mental status Unstable vital signs: BP= 90 mmHg or = 180 mmHg , PR=150 or =50 bits/min , RR=10 or =30 History of recent head or eye trauma History of Siesure History of elevated ICP Chronic pain Renal or hepatic failure Substance or alcohol abuse Documented psychiatric disorders Opium addiction Recent use of narcotic analgesics

Design outcomes

Primary

Measure	Time frame
Pain score. Timepoint: Minute 0, 5, 10, 15, 30. Method of measurement: Scoring 1 to 10.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPooya Payandemehr

Tehran University of Medical Sciences

pooya_mehr@yahoo.com+98 21 6634 8500

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026